Shingles can strike at any age, but it overwhelmingly affects people over 50. About half of all cases occur in adults 60 and older, and the risk climbs steeply with each decade after that. The reason is straightforward: the immune defenses that keep the virus dormant weaken as you age, and at some point they can no longer hold it in check.
Why Age Matters So Much
Anyone who has had chickenpox carries the varicella-zoster virus for life. After the initial infection clears, the virus retreats into sensory nerve cells near the spine and brain, where it stays inactive. Your immune system, specifically a group of T cells trained to recognize this virus, acts as a constant guard keeping it suppressed.
As you get older, those T cells decline in both number and function. This gradual erosion of immune surveillance is the primary driver behind shingles. Once the T-cell response drops below a critical threshold, the virus can reactivate, travel along a nerve fiber to the skin, and produce the painful blistering rash. This process explains why shingles is relatively rare in younger adults and increasingly common after 50: it tracks directly with the natural aging of the immune system.
The Peak Risk Decades
Risk begins to rise meaningfully around age 50 and accelerates from there. People in their 60s are several times more likely to develop shingles than people in their 40s, and those in their 70s and 80s face the highest rates of all. Roughly one in three people in the United States will develop shingles at some point in their lifetime, and the majority of those cases cluster in the later decades.
The complications also get worse with age. Postherpetic neuralgia, a condition where burning or stabbing nerve pain lingers for months after the rash heals, affects an estimated 12.5% of shingles patients aged 50 and older. That proportion increases sharply with each additional decade. Studies find the relative risk of postherpetic neuralgia rises by 22% to as much as threefold for every 10-year jump in age. In practical terms, an 80-year-old who gets shingles is far more likely to end up with lasting pain than a 55-year-old with the same rash.
Shingles in Younger Adults and Children
While uncommon, shingles does happen in people under 50. Younger cases tend to be milder and less likely to cause lingering nerve pain, but they aren’t trivial. Rates among adults in their 20s, 30s, and 40s have gradually increased over the years in the United States, though they’ve recently leveled off. The CDC has not identified a clear reason for the earlier rise.
Children can get shingles too, though it’s rare. A large study tracking over 6 million children from 2003 to 2014 found an overall incidence of 74 cases per 100,000 children per year. Kids who had received the chickenpox vaccine developed shingles at a rate 78% lower than unvaccinated children (38 vs. 170 per 100,000). By 2014, overall childhood shingles rates had dropped 72% compared to the start of the study period, largely because of widespread vaccination. The chickenpox vaccine uses a weakened form of the virus, which still establishes latency in nerve cells but reactivates far less often than the wild-type virus from a natural infection.
When Immune Conditions Change the Timeline
Age isn’t the only thing that can weaken the T-cell response keeping shingles at bay. People with compromised immune systems face elevated risk regardless of how old they are. The conditions and treatments that raise risk most include:
- Blood cancers such as lymphoma and leukemia
- Organ or bone marrow transplants and the anti-rejection drugs that follow
- HIV, particularly when immune cell counts are low
- Cancer chemotherapy
- Long-term corticosteroid use, especially at higher doses for two weeks or more
- Immune-suppressing medications used for autoimmune diseases like rheumatoid arthritis, Crohn’s disease, or lupus
For these individuals, shingles can appear in their 20s, 30s, or 40s at rates that would otherwise be seen in much older adults. The episodes also tend to be more severe, with a higher chance of the virus spreading beyond a single strip of skin to affect multiple areas or internal organs.
Vaccination and Timing
The CDC recommends two doses of the recombinant shingles vaccine (Shingrix) for all adults aged 50 and older. For adults 19 and older who are immunocompromised or expect to become so because of upcoming treatment, the recommendation starts earlier. This two-tier guideline reflects the two main pathways to shingles: natural immune aging and medical immune suppression.
The vaccine works by boosting the very T-cell response that declines with age, essentially reinforcing the guard that keeps the dormant virus contained. It’s recommended even if you’ve already had shingles, since recurrence is possible. Overall, only about 1 to 4% of people who’ve had one episode will get a second, but that rate is higher in those with chronic immune-suppressing conditions.
If you’re approaching 50 and had chickenpox as a child, the virus is already inside your nerve cells. The question isn’t whether it’s there, but whether your immune system will keep holding it back. That’s the calculation that makes age the single strongest predictor of when shingles appears.